News
Genie Energy Ltd (GNE) Q3 2019 Earnings Call Transcript
Ziopharm Oncology Inc (ZIOP) Q3 2019 Earnings Call Transcript
Ziopharm Oncology Inc (NASDAQ: ZIOP)Q3 2019 Earnings CallNov 7, 2019, 4:30 p.m. ET
Operator
Source Fool.com
Stoke Therapeutics to Present at Upcoming Investor Conferences in November
Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company pioneering a new way to treat the underlying cause of severe genetic diseases by precisely upregulating protein expression, today
Keane Group, Inc. (FRAC) Q3 2019 Earnings Call Transcript
Keane Group, Inc. (NYSE: FRAC)Q3 2019 Earnings CallNov 7, 2019, 11:30 a.m. ET
Operator
Source Fool.com
InnerWorkings Announces Third Quarter 2019 Results
InnerWorkings, Inc. (NASDAQ: INWK), the leading global marketing execution firm, today announced financial results for the three and nine months ended September 30, 2019. For all non-GAAP
Focus Financial Partners Inc (FOCS) Q3 2019 Earnings Call Transcript
Focus Financial Partners Inc (NASDAQ: FOCS)Q3 2019 Earnings CallNov 7, 2019, 11:30 a.m. ET
Operator
Source Fool.com
Denbury Resources Inc (DNR) Q3 2019 Earnings Call Transcript
Denbury Resources Inc (NYSE: DNR)Q3 2019 Earnings CallNov 7, 2019, 11:00 a.m. ET
Operator
Source Fool.com
Veeva to Release Fiscal 2020 Third Quarter Results on November 26, 2019
Veeva Systems (NYSE:VEEV) will announce financial results for its third quarter which ended October 31, 2019 after the market close on November 26, 2019. Veeva will host a conference call and
GE Healthcare Announces U.S. FDA Approval of Macrocyclic MRI Contrast Agent Clariscan™ (gadoterate meglumine) Injection for Intravenous Use
The U.S. Food and Drug Administration (FDA) has approved Clariscan™, a macrocyclic, ionic, gadolinium-based, MRI contrast agent, expanding the GE Healthcare portfolio for U.S. patients and
Almirall Makes Shift to Specialty Medicine with Veeva CRM
Veeva Systems (NYSE:VEEV) today announced that Almirall selected multichannel Veeva CRM to deliver seamless customer experience across all channels as it shifts business focus to specialty
JPMorgan Chase Files Form 10-Q for the Quarterly Period Ended September 30, 2019
JPMorgan Chase & Co. (NYSE: JPM) (“JPMorgan Chase” or the “Firm”) has filed its Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2019 with the SEC. The report is available
GeoPark Reports Third Quarter 2019 Results
GeoPark Limited (“GeoPark” or the “Company”) (NYSE: GPRK), a leading independent Latin American oil and gas explorer, operator and consolidator with operations and growth platforms in Colombia
Ryder Chairman & CEO to Address Stephens Nashville Investment Conference
Ryder System, Inc. (NYSE: R) Chairman & Chief Executive Officer Robert Sanchez will present a company update at the Stephens Nashville Investment Conference.
Who:
Ryder System, Inc
Eros International Plc Acquires International Distribution Rights To Four Bollywood Films
Eros International Plc (NYSE: EROS) (“Eros” or the “Company”), a Global Indian Entertainment Company, announced today that it will release four Hindi language films across different genres later
Synlogic Announces Third Quarter 2019 Conference Call and Webcast
Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company applying synthetic biology to beneficial microbes to develop novel, living medicines, announced today that the Company will release its third
TD Ameritrade Investor Movement Index: IMX Rises as Investors React to Earnings Season
The Investor Movement Index® (IMXSM) increased to 4.84 in October, up 7.3 percent from its September score. The IMX is TD Ameritrade’s proprietary, behavior-based index, aggregating Main Street
First Internet Bancorp Closes Acquisition of Small Business Lending Division
First Internet Bancorp (“First Internet” or the “Company”) (Nasdaq: INBK) announced today that its subsidiary, First Internet Bank (the “Bank”), has completed the previously announced acquisition
Lineage Cell Therapeutics to Report Third Quarter 2019 Financial Results and Provide Business Update on November 12, 2019
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, announced today that it will report
Veeva Completes Acquisition of Crossix
Veeva Systems (NYSE:VEEV) today announced it has completed its acquisition of Crossix Solutions. Trusted by more than 200 pharmaceutical brands, Crossix provides privacy-safe U.S. patient data and
NOW Inc. Reports Third Quarter 2019 Results
NOW Inc. (NYSE: DNOW) announced results for the third quarter ended September 30, 2019.
Earnings Conference Call
November 6, 2019
8:00 a.m. CST
1 (800) 446-1671 (North America)
1 (847) 413-3362
Changes to the Pernod Ricard Executive Committee
Regulatory News:
Press release – 7 November 2019
Pernod Ricard (Paris:RI) announces that Paul Duffy, Chairman & Chief Executive Officer of Pernod Ricard North America and a member of the
IMV Inc. Announces Third Quarter 2019 Financial Results and Provides Corporate Update
IMV Inc. (TSX: IMV; NASDAQ: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of immunotherapies, today announced its financial and operational results for the third quarter
Pitney Bowes Announces Third Quarter 2019 Financial Results
Pitney Bowes Inc. (NYSE: PBI), a global technology company that provides commerce solutions in the areas of ecommerce, shipping, mailing, data and financial services today announced its financial
Semtech’s LoRa® Devices Enable AMI Metering Applications for Smarter Utility Management
Semtech Corporation (Nasdaq: SMTC), a leading supplier of high performance analog and mixed-signal semiconductors and advanced algorithms, announced that NSOFT, a leading Indian provider of
Unit Corporation Reports 2019 Third Quarter Results
Unit Corporation (NYSE: UNT) today reported its financial and operational results for the third quarter of 2019. Operational highlights include:
Oil and natural gas segment:
-
Segment production